Neuland

Saharsh Davuluri


Defining the Contract Pharma Provider Relationship

I read an article at Pharmaceutical Manufacturing earlier this year (Inking the Deal: Mastering the art of lasting outsourcing relationships in the pharmaceutical industry) on the nature of contract pharma…

Posted in agreement, CMC, Contract Manufacturing, CRO/CMO, method development, Neuland Labs, outsourcing, Project Management | Leave a comment

Orphan Drug Manufacturing: Less Lifecycle Management, More Process Optimization

Rare (or orphan) diseases may sound like a small, low-prevalence problem – hence their labeling as ‘rare.’ But with 7,000+ rare diseases having already been identified, affecting more than 50…

Posted in API synthesis, Capabilities, Contract Manufacturing, drugs, Orphan drug, orphan drugs | Leave a comment

Unveiling Neuland’s Process Engineering Lab: Tightening our Focus on QbD

Neuland has recently welcomed the addition of a new, dedicated Process Engineering Lab to its R&D Center. The lab opened in March, and supports operations and safety studies via a…

Posted in process chemistry, Process Engineering, Process Engineering Lab, QA/QC, QbD, Quality, R&D | Leave a comment

Reflections on the CPhI Barcelona Show

The 2016 Barcelona CPhI show (CPhI Worldwide) was an excellent opportunity for Neuland to set in place some strengthened internal sales team processes. These processes allowed us to better capture…

Posted in Uncategorized | Leave a comment

Defining the Relationship Between the Pharma Industry & Regulatory Agencies

I read an article at PharmTech at the tail end of 2016 that I thought was quite interesting, and it reflects Neuland’s position on regulatory agencies & issues. The article…

Posted in Contract Manufacturing, CRO/CMO, drugs, FDA, Neuland Labs, Pharm Tech, Pharmaceutical Technology, Quality, regulatory | Leave a comment

Peptide Therapeutics infographic

Posted in APIs, Fmoc, Neuland Labs, peptide, peptides, process chemistry, scale-up, synthesis | Leave a comment

Niche Growth & Growing Niches: A Market Report on APIs and Eroom’s Law

A recent market report on APIs by Future Market Insights (FMI) paints a generally rosy economic picture of the industry over the next decade, but in this case the report’s…

Posted in API synthesis, APIs, Contract Manufacturing, drug discovery, drugs, Neuland Labs, peptide, peptides, Pharm Tech, Pharmaceutical Technology | Leave a comment

8 Ways to Strengthen Your API Supply Chain Management and Sourcing

A pharmaceutical manufacturer is only as good as its supply chain. Supply chain management and strategic sourcing are the key drivers which keep operations running smoothly. Set the Right Inventory…

Posted in APIs, CMC, Contract Manufacturing, FTR, KSM, OTIF, supply chain | Leave a comment

In Pharma, Quality is Everything. All Else is Secondary.

We are firm believers that quality is more important than…well…everything in the pharma business. It’s very simple: in this highly-regulated industry, without quality – a company has no value. We…

Posted in Neuland Labs, QA/QC, Quality | Leave a comment

How Process Engineering Techniques Result in Cost-Effective Products

With the cost pressures of today’s competitive market, active pharma ingredient (API) sales profit margins are continuously falling. As a result, pharmaceutical manufacturers find themselves under pressure to cut production…

Posted in Chemistry, Contract Manufacturing, method development, Neuland Labs, PAT, process chemistry, Process Engineering, Project Management | Leave a comment